Literature DB >> 6463244

Hepatic infarction with absolute ethanol.

D O'Riordan, H McAllister, B J Sheahan, D P MacErlean.   

Abstract

Ethanol was used to embolize the hepatic artery in 7 dogs, producing occlusion proportional to the dose employed. On follow-up angiography at 1 and 4 weeks, occlusion was unchanged or more pronounced, indicating that such embolization is permanent. Because ethanol is nonviscous and easy to use, it is effective in occluding the hepatic arterial system. Perisinusoidal fibrosis is produced.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6463244     DOI: 10.1148/radiology.152.3.6463244

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Hepatic artery embolization of experimental hepatic tumors with absolute ethanol.

Authors:  O Matsui; I Kawamura; M Kadoya; T Takashima; Y Nakanuma
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

2.  Bile duct strictures associated with hepatic arterial infusion chemotherapy.

Authors:  R A Clark; T E Gallant
Journal:  Gastrointest Radiol       Date:  1987

3.  Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor model.

Authors:  Feng Gao; Ting Qian; Mao Zhen Chen; Hua Bin Yin; Ya Li Xu
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

4.  Experimental transcatheter hepatic subsegmentectomy using absolute ethanol in dogs.

Authors:  N Kokudo; Y Nomura; H Koyama; Y Otomo; K Ohashi; K Sanjo; Y Idezuki
Journal:  Jpn J Surg       Date:  1990-09

5.  Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma.

Authors:  M Koda; K Okamoto; Y Miyoshi; H Kawasaki
Journal:  Gastrointest Radiol       Date:  1992

6.  Intra-arterial alcoholization of advanced hepatocellular carcinoma.

Authors:  K Ito; H Kusunoki; E Okamoto; M Ozawa; A Ishikawa; M Matsuura; N Nakajima
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.